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Available information on the molecular mechanisms by which nitric oxide (NO) controls the activity of the respiratory enzyme (cytochrome-c-
oxidase) is reviewed. We report that, depending on absolute electron flux, NO at physiological concentrations reversibly inhibits cytochrome-c-
oxidase by two alternative reaction pathways, yielding either a nitrosyl- or a nitrite-heme a3 derivative. We address a number of hypotheses,
envisaging physiological and/or pathological effects of the reactions between NO and cytochrome-c-oxidase.
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Eighty years ago, Otto Warburg [1] discovered that
inhibition of respiration by carbon monoxide (CO) can be
reversed by light. In studying the O2 consumption by yeast cells
in the presence of CO in the gas phase, he developed a method
based on the photochemical recovery of respiration by
dissociation of CO bound to the respiratory enzyme. Photosen-
sitivity of the adduct between hemoglobin and CO had been
demonstrated years before by Haldane and Lorrain-Smith [2].
The effect of light, which allowed Warburg to unveil that heme
is the prosthetic group of the respiratory enzyme, is due to the
much higher quantum yield of photodissociation of CO as
compared to O2 bound to reduced heme proteins. By measuring
the rate of respiration recovery as a function of the wavelength
of the irradiating light in the presence of variable mixtures of O2
and CO, Warburg and Negelein [3] determined the photochem-
ical action spectrum of the respiratory enzyme (Fig. 1). It is
remarkable to see the spectrum of cytochrome-c-oxidase
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doi:10.1016/j.bbabio.2006.05.011It should be recalled that CO is a poor inhibitor of
cytochrome-c-oxidase activity, a fact which seems ignored in
most Physiology and Biochemistry textbooks; it takes almost
100-fold excess of CO over O2 to inhibit the enzyme. On
the other hand, about 10 years ago it was discovered that
nitric oxide (NO) is a very efficient inhibitor of cellular
respiration [4–8]. Since it had been known for decades that
NO binds to reduced cytochrome-c-oxidase very rapidly [9],
it may seem surprising that inhibition of O2 consumption by
NO was convincingly documented only in the 1990s. This is
partly related to the fact that at low concentrations, the
lifetime of solvated NO is quite long even in the presence of
excess O2. The reaction of NO with O2 in solution is
described by a complex mechanism, which is second order
in NO and first order in O2 [10,11]. Therefore, at
concentrations of NO similar to those prevailing under
physiological conditions [12], NO degradation is quite slow,
the lifetime of NO at physiological O2 concentrations (but
even in air) being of the order of at least many seconds.
Carr and Ferguson [4] showed that NO catalytically
generated by Paracoccus denitrificans nitrite reductase was
able to inhibit O2 consumption of beef heart mitochondrial
particles; indeed these authors concluded that NO was
sufficiently stable to inhibit cytochrome-c-oxidase activity
under the conditions of the assay.
Fig. 1. Photochemical action spectrum of the respiratory enzyme. The
photochemical action spectrum of cytochrome-c-oxidase (as the CO derivative)
determined by Warburg and Negelein [3] following the reversal of inhibition
induced by light at different wavelengths (from the Nobel lecture by O.
Warburg, 1931).
Fig. 2. Model of the complex between mtNOS and cytochrome-c-oxidase. The
two monomers of beef heart cytochrome-c-oxidase are depicted in dark and light
blue, respectively, with the mtNOS-PDZ domain (in gray-green) bound to the
last nine residues of subunit Va of the oxidase (in red). The PDZ domain used for
modeling is from the 3D structure of the NOS-I PDZ domain in complex with a
synthetic heptapeptide derived from the C-terminal domain of the melatonin
receptor (melR-PDZ, Protein Data Bank code 1B8Q [96]). Reproduced from
[43] with permission.
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the effect of NO on cellular respiration. The target enzyme of
the inhibitory pattern was unequivocally shown to be
cytochrome-c-oxidase in 1994 [5–8]; spectroscopic evidence
as well as the expected competition between O2 and NO were
taken as evidence that the target was indeed the respiratory
enzyme. Considering the great importance of NO as a
fundamental second messenger involved in a large number of
patho-physiological processes, it is not surprising that many
more investigations on the reactions of NO with cytochrome-c-
oxidase followed (reviewed in [13–15]). Evidence has been
accumulated showing that NO inhibits cytochrome-c-oxidase at
all integration levels ranging from mitochondria to tissues up to
in vivo [5–8,16–24]. Activation of cultured astrocytes by
interferon-γ to express inducible NO synthase (NOS) yielded a
decrease in O2 consumption, and the effect was shown to be
reversed by addition of NOS inhibitors or hemoglobin (to
scavenge NO) [16]. Similarly, respiration in endothelial cell was
shown to be transiently inhibited upon stimulation of
endothelial NOS by bradykinin [18]. Experiments of this kind
prove that endogenous production of relatively low concentra-
tions of NO (<1 μM) is actually sufficient to induce inhibition.
Nevertheless the significance of NO in regulating O2 consump-
tion remains a challenge, and in fact only in a few cases it was
demonstrated that, without external NOS stimulation, basal
steady state fluxes of endogenous NO (which range in the cell
from 10 to over 100 nM) are associated to inhibition of
cytochrome-c-oxidase and thereby modulation of respiration in
the cell [19]. In fact, this observation was presumed to account
for the higher value of the KM for O2 observed in cells and
tissues as compared to purified cytochrome-c-oxidase [25].
2. The source of NO
As outlined above, in aqueous solution the lifetime of NO
at the physiological concentrations prevailing in the cell isquite long (minutes); in parenchymal tissues (hepatocytes) the
half-life of NO was predicted to be much shorter (from 0.09
to 2 s), but still long enough to allow NO diffusion up to
several hundreds microns [26]. Therefore, NO produced by
endothelial NOS can indeed diffuse from the site of
production to other cells, and combine with the physiological
and primary target which is soluble guanylyl cyclase [27,28].
It may be relevant to ask whether NO produced by
endothelial cells can actually inhibit cytochrome-c-oxidase
when diffusing in the muscles. It appears that NO reaching
the myocytes will be largely, if not totally, quenched by
oxymyoglobin which is known to react irreversibly and very
rapidly (over 107 M−1 s−1 [29,30]) with NO yielding nitrate.
This important function of myoglobin was highlighted by
Brunori [31] with reference to the inhibition of cytochrome-c-
oxidase; the crucial role of myoglobin as a NO quencher was
demonstrated by clever experiments on knockouts in mice
[32]. Consistently, myocardial O2 consumption is not
controlled by endothelial NO production [33].
In other cells producing basal concentrations of NO, the
gas can easily diffuse to and through mitochondria, and
therefore meet its target(s). It is obviously interesting to ask if
inhibition of oxidase by NO is an unfortunate accident that
we have to live with, or it underlies a regulatory mechanism.
The problem is rather subtle and has been debated over the
last 10 years [34]. The proposal that a bona-fide mitochon-
drial NOS exists [35–39] would be an important step forward
in maintaining that NO is involved in a control mechanism of
cellular respiration; in spite of available experimental
evidence, the existence of such an enzyme is still debated
(see [40–42] for recent reviews on this issue). However, very
recently, it was reported [43] that mitochondrial NOS can
interact specifically with cytochrome-c-oxidase by binding to
subunit Va of this enzyme, through a PDZ domain (Fig. 2).
This further supports the viewpoint that the NO controlling
Table 1
Rate constants for the reactions of reduced beef heart cytochrome c oxidase with
O2, CO and NO
O2 CO NO
kon (M
−1 s−1) ∼2×108 8×104 0.4–1×10
koff (s
−1) ? 0.023 4×10−3
Buffer: 0.1 M phosphate pH=7.0–7.5. Detergent: 1% Tween 80 or 0.1%
dodecyl-β-D-maltoside. Temperature=20 °C.
1146 M. Brunori et al. / Biochimica et Biophysica Acta 1757 (2006) 1144–11548Fig. 3. The active site. Heme a3 (in green) and CuB (in magenta) in the binuclear
center of beef heart cytochrome-c-oxidase in the fully oxidized state. The heme
Fe is coordinated by His 376, whereas CuB by His 291, His 290 and His 240, the
last residue being covalently bound to Tyr 244. From the Protein Data Bank
coordinates deposited by Tsukihara et al. [47,48].respiration is produced in situ by mitochondrial NOS, and
indeed is probably synthesized in the immediate environment
of the enzyme. The scenario stimulates additional questions
related to the regulatory role of NO on cellular respiration. On
one hand, it may be useful to re-evaluate the stoichiometric
ratio of mitochondrial NOS relative to the different respiratory
complexes; in addition the topology of respiratory complexes
and their synchronized activation within a mitochondrion
should be considered. Finally, it became obvious that
understanding in depth the mechanism of inhibition of
cytochrome-c-oxidase by NO is mandatory. This is the main
issue dealt with in this review.
3. Binding of gaseous ligands
Table 1 reports a summary of the rate constants for the
binding of O2, CO and NO to reduced cytochrome-c-oxidase
(from beef heart). The kinetics of these reactions have been
extensively studied. In the concentration range up to mM, the
initial phase of combination corresponds, in all cases, to a
second order process. The values reported in Table 1 explain
why CO is a poor competitor of O2, and thereby a very
inefficient inhibitor of respiration. However, it is not
immediately obvious why NO should be a very efficient
competitor of O2 because the combination rate constants of
the two gases are very similar and under physiological
conditions the average concentration of O2 in the cell (from 2
to 20 μM) is much greater than that of NO (from 10 to
100 nM). A relevant point in this respect is that the reaction
with NO is reversible, and indeed Sarti and collaborators [44]
measured a rate of dissociation (koff =3.9×10
−3 s−1, at
20 °C) which was unexpectedly high compared, for example,
to hemoglobin; at 37 °C this rate constant is obviously
greater. On the other hand, binding O2 is considered
essentially irreversible because of a very fast electron transfer
trapping event [9,45].
It may be relevant to point out that when the reaction with
these ligands is followed at much higher concentrations (say
up to 10 or 20 atm), the kinetics reveals a more complex
physical mechanism (see [46] and references therein). With
CO, the results are quite unequivocal, but even with O2
essentially similar data suggest that the gas diffusing from the
bulk to its target (reduced heme a3) docks momentarily on
CuB
+, the other metal in the active site of cytochrome-c-
oxidase. By analogy with CO, it may be argued that NO also
uses CuB
+ as a temporary station on the way to heme a3. A
brief outline of some aspects of the structure of cytochrome-c-
oxidase, as emerged from X-ray crystallography, is in order.4. The structure of the respiratory enzyme
The 3D structure is available for beef heart cytochrome-c-
oxidase [47–50] as well as for three bacterial oxidases (the aa3-
type from Paracoccus denitrificans [51–53] and Rhodobacter
sphaeroides [54], and the ba3-type from Thermus thermophilus
[55,56]). In most cases, the structure was solved with the
oxidized enzyme, but structures of the fully reduced state either
unliganded or bound to CO are also available.
The reaction with reduced cytochrome c (the e- donor)
involves the bimetallic CuA site, located in a globular domain of
subunit II protruding into the mitochondrial intermembrane
space. This binuclear CuA site accepts one electron from
reduced cytochrome c, and in turn reduces rapidly (by
intramolecular eT) heme a, located 19 Å away (CuA-to-Fea
distance). Heme a is a bis-histidine low-spin heme, bound to
subunit I and buried within the membrane-embedded part of the
enzyme. Although reduction of heme a occurs without
reorganization, structural changes around this site were
observed in the beef heart enzyme [49,50]. From heme a,
electrons are transferred intramolecularly to the active site, the
binuclear heme a3 and CuB center, where the gaseous ligands
(O2, CO and NO) bind. While O2 and CO binding demands the
complete reduction of this binuclear site, this is not necessarily
the case for NO.
Heme a and heme a3 (Fea-to-Fea3 distance of 14 Å) are at
approximately the same depth within the membrane-spanning
moiety of subunit I; this notwithstanding, eT is electrogenic
being coupled to an uptake of protons from the mitochondrial
matrix. The distance between the iron of heme a3 and CuB is
short and depends on the redox-state in the beef heart enzyme
(4.9 Å in the fully oxidized and 5.2 Å in the fully reduced state).
Heme a3 is coordinated to one histidine (H376) on the
“proximal” side, whereas CuB is coordinated by three histidines
(H290, H291 and H240) (Fig. 3). It was a surprise to discover
that one of the CuB histidine ligands (H240) makes a covalent
bond with an adjacent tyrosine (Y244) [49,52]; this would
lower the pKa of Y244, making this residue a possible proton
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been postulated to be in a radical state in one of the O2
intermediates of the catalytic cycle [57].
In the oxidized beef heart enzyme, a magnesium ion at the
interface between subunits I and II was observed. Since the Mg
site is located on the top of the heme a3-CuB site, it has been
suggested to be located in the exit pathway for protons/water
molecules [58].
In the fully oxidized state, an electron density between the
iron of heme a3 and CuB was identified, although its
interpretation is quite controversial. In the beef heart enzyme,
this was attributed to a bridging peroxide; on the other hand, in
R. sphaeroides and in T. thermophilus, this density was fitted to
just one bridging oxygen (OH− or H2O). Although undetected
by X-ray crystallography, solution experiments strongly suggest
that a Cl− ion is bound to oxidized CuB (replacing the OH
−) in
the resting enzyme purified in the presence of chloride. In the
fully reduced state, on the other hand, there is no electron
density between the two metals. Moreover a conformational
change upon enzyme reduction was observed in the beef heart
enzyme [49,50] involving subunit I D51, which is connected
through a H-bonding network to the formyl group of heme a.
Upon reduction, D51 becomes exposed to the intermembrane
space and a water channel, linking heme a to the matrix space,
increases its volume; hence Yoshikawa suggested that this
structural transition may be involved in proton pumping [59].
Ligand binding to the fully reduced enzyme does not appear
to induce major conformational changes, as inferred from
inspection of the 3D structure of the CO adduct of reduced beef
heart enzyme at 2.8 Å [49]; CO binds to ferrous heme a3 in a
bent configuration at 2.5 Å from CuB.
In summary, cytochrome-c-oxidase appears to be a fairly
rigid protein, showing some conformational changes upon
reduction but none upon CO binding. However, FTIRFig. 4. The catalytic cycle. The catalytic intermediates of cytochrome-c-oxidase are de
the redox states of heme a and CuA are not indicated. For each intermediate, the schem
PM species) and the half-time of the decay as measured in the reaction of the fully redu
permission.spectroscopy provided evidence for structural changes associ-
ated to reduction and/or ligand binding [60]; hence, it would not
be surprising if subtle but possibly significant conformational
changes may be observed at a higher resolution.
5. Oxygen reduction mechanism
Evidence for intermediates in the reaction of O2 with reduced
cytochrome-c-oxidase in solution at room temperature has been
obtained (by-and-large) using the “flow-flash” approach
introduced by Gibson and Greenwood [9] over 40 years ago.
The CO derivative of beef heart cytochrome-c-oxidase is mixed
with an oxygenated buffer, and immediately (<0.1 s) hit with a
short pulse of light. The binuclear site stripped of CO is free to
bind O2, and the formation and decay of several intermediates
can be followed from μs upwards by time-resolved spectros-
copy (mostly UV/vis absorption and Resonance Raman). In
addition, O2 intermediates were extensively studied and
characterized when trapped at low or ultra-low temperatures,
using essentially the triple-trapping method introduced by B.
Chance and coworkers [61].
A scheme showing the intermediates in the reaction with O2
is reported in Fig. 4. Upon CO-photolysis (not shown) O2
rapidly (t1/2 ∼10 μs) combines with reduced heme a3 of species
R yielding the first intermediate, called compound A; the rate of
formation of this species, a real O2 adduct, is [O2] dependent.
Compound A is short-lived due to very fast delivery of electrons
to bound O2. Depending on the possibility of eT from heme a, A
yields two (apparently) distinct intermediates, collectively
called P (for peroxy). If an electron is available on heme a,
the so-called PR intermediate is formed (t1/2 ∼40–50 μs); in the
absence of further electrons besides those residing on the heme
a3-CuB site, A decays to PM (t1/2 ∼300 μs). The latter
intermediate can be obtained in a relatively stable form (fewpicted with the indication of the redox and the ligation state of heme a3 and CuB;
e shows the presumed state of Tyr 244 (assumed to have radical character in the
ced enzyme with O2 by the flow-flash technique [9]. Reproduced from [46] with
Fig. 5. The reversible inhibition of respiration by endogenous NO. Traces
collected with selective electrodes for NO (top) and O2 (bottom). The respiration
of astrocytes (0.65 mg protein ml−1) is partially inhibited due to activation of the
inducible NOS by incubation with lipopolysaccharide and interferon-γ.
Inhibition is reversed upon addition of the NOS inhibitor NG-methyl-arginine
(NMA); then it is restored following the addition of the NOS substrate arginine;
finally respiration picks up again after depletion of NO by addition of oxy-
hemoglobin. Reproduced from [16] with permission.
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enzyme (the CO complex of an enzyme with reduced heme a3
and CuB, but oxidized heme a and CuA) [62].
The initial hypothesis that P could be a peroxy-complex with
oxidized heme a3 and CuB had to be revised, and nowadays
there is a consensus on the idea that PM and PR are both oxo-
ferryl adducts [63–65]. This implies that the O\O bond is
already cleaved and, therefore, both O atoms are already at
oxidation level=−2. In the case of PM, this demands overall
delivery of 4 electrons, though only 3 are formally available in
the heme a3-CuB center (2 from Fea3 and 1 from CuB), leading
to the suggestion that Y244 could provide the missing electron.
Since in the case of PR, the fourth electron is provided by heme
a, in this intermediate the involvement of a protein residue
seems unlikely, though not yet excluded.
PM and PR both convert into the same intermediate (called F),
through distinct pathways and kinetics. The decay of PR is fast
(t1/2∼100 μs) and demands no further eT from heme a, while PM
can proceed in the catalytic cycle only at the rate of arrival of a
further electron from heme a. F is also an oxo-ferryl inter-
mediate, which coverts to the fully oxidized state O upon arrival
of one more electron from CuA/heme a (t1/2 ∼1–1.5 ms).
A point may be made to contrast the very short half-life of
the intermediates with their populations, during turnover. The
population of these intermediates (say P and F) is very small
when and if the full complement of 4 electrons is already stored
in the enzyme, as for the fully reduced species; however this is
not necessarily so during turnover, given that the rate of electron
entry from cytochrome c (via CuA and heme a) can become rate
limiting. Under these conditions, the population of the
intermediates can grow, which is relevant to the mechanism
of inhibition by NO (see below).
6. NO inhibition
The great interest for a possible role of NO in controlling
cellular respiration stimulated a number of studies on the
mechanism of inhibition. As shown in several laboratories,
inhibition of cytochrome-c-oxidase by NO is very effective,
with an apparent inhibition constant that is in favour of NO over
O2 by a factor of at least of 100, if not more [6,66]. This is
significant when considering the overall effect of NO on cellular
respiration since it is known that also Complex I is inhibited by
NO, as shown years ago by Clementi and collaborators [67].
However, inhibition of Complex I occurs quite slowly after
exposure to high levels of NO, and it seems to be a long term
effect, whereas cytochrome-c-oxidase is inhibited very rapidly
by fairly low NO concentrations even in the presence of a large
excess of O2. By stopped-flow spectroscopy, it was shown that
the onset of NO inhibition of cytochrome c oxidation under
aerobic conditions takes only seconds or less [68]. This was
quite unexpected vis-à-vis the similar second order rate
constants for the binding of O2 and NO to the reduced binuclear
center (Table 1). Indeed this was the motivation to propose
[66,68] that contrary to O2, NO binds not only to the fully
reduced but also to a partially reduced binuclear center. In
looking at the O2 intermediates in the overall cycle (as reportedin Fig. 4), it may be seen that in going from O to R a partially
reduced binuclear center, called E, has been postulated; it is
assumed that this species has a single electron residing either on
heme a3 (E1) or on CuB (E2). It is well established [69] that both
CO and O2 bind only to the fully reduced binuclear center, i.e.,
to R; this reaction occurs also if the other metal centers in the
enzyme (i.e., heme a and CuA) are in the oxidized state [62].
Indeed the preparation of the so-called mixed-valence CO
complex took advantage of the fact that CO can stabilize the
fully reduced binuclear center under conditions in which heme a
and CuA are both oxidized. On the other hand NO can, in
principle, bind when only heme a3 is reduced and, a priori,
there is no obvious reason to exclude that such a partially
reduced species could be highly reactive towards NO. Giuffrè et
al. [70] reported an experiment on a Paracoccus denitrificans
oxidase mutant (K354M) which indeed supports the contention
that a partially reduced binuclear center can bind NO rapidly. If
this was the case, then the kinetic efficiency of NO in competing
with O2 may be more easily accounted for. Simulations carried
out by Giuffrè et al. [68], actually indicated that the presence of
two potential targets for NO (i.e., R and E1) would account for
the O2/NO competition in steady-state experiments. However,
this point remains debated since other groups proposed (i) that
the reaction of NO with E occurs at CuB
+, and not at ferrous
heme a3 [66] and (ii) that reaction with E is unnecessary to
account for steady-state data [71].
Another important feature of the inhibition of cytochrome-c-
oxidase by NO is its reversibility. Recovery of O2-oxidoreduc-
tase activity can be demonstrated in a simple polarographic
assay (Fig. 5). If NO is quenched rapidly (for example by
addition of a NOS inhibitor or oxyhemoglobin) then respiration
picks-up again [16,44]. Under normal assay conditions, the NO
concentration in solution tends to decrease with time because O2
in excess will destroy NO, slowly but irreversibly. Under these
conditions, it was proven that reversal of inhibition demands
dissociation of NO, and no redox chemistry takes place at the
binuclear site [72]. Although dissociation of the gas is relatively
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illumination. Using this approach, Sarti et al. [44] showed that
rate of respiration recovery is increased considerably by light,
but only when cytochrome-c-oxidase is inhibited via the
formation of an adduct of the reduced enzyme with NO (see
below). This experiment obviously mimics to the historical
result published by Warburg [1], which demonstrated that the
respiratory enzyme contains heme.
7. Reaction with oxidized CuB
The reaction of fully oxidized cytochrome-c-oxidase with
NO had been investigated in the early 1980s [73]. It was
reported that NO binds to oxidized CuB in a reaction which is
extremely slow, which we now attribute to the fact that at the
time everybody was working with the so-called resting enzyme.
These experiments in fact had to be reinterpreted after the
discovery by Antonini et al. [74] that oxidase exists in a pulsed
state which is populated immediately after exposure of the fully
reduced enzyme to O2. The product of this pulsing reaction has
spectroscopic and reactivity properties which are different from
those of the enzyme as prepared. This procedure was followed
to show that the pulsed and resting states have different
reactivity towards ligands of the ferric enzyme, such as cyanide
(see [75] for a review).
The reactivity of the oxidized enzyme with NO was clarified
by an observation reported by Cooper et al. [76]. These authors
discovered that using a pulsed (or fast) preparation of
cytochrome-c-oxidase, NO reacts rapidly with CuB injecting
one electron in the enzyme. This process is associated to
synchronous reduction of heme a, with formation of NO2
−.
Giuffrè et al. [77] subsequently showed that the rapid reaction of
oxidized CuB with NO follows second-order kinetics
(k=2×105 M−1 s−1 at 20 °C) and does not occur with the
enzyme as prepared, since the resting state has chloride bound
to the enzyme which can be removed by pulsing the oxidase.
The interesting point emerging from these findings is that the
formation of NO2
− in the pocket leads to transient binding to theFig. 6. Reaction of NOwith the catalytic intermediates of cytochrome-c-oxidase. Inter
adduct of the oxidized heme a3 (bold), whereas those having reduced heme a3 (squ
former reaction is favored at low electron flux, while the latter prevails at higher ele(nearby) oxidized heme a3, with formation of a nitrite-ferric
heme a3 complex. This species, which is formed synchronously
with eT from NO to CuB (and thereby heme a) has
spectroscopic properties identical to those that can be obtained
by addition of a large excess (>mM) of nitrite to the oxidized
enzyme. This NO2
− adduct is inhibited in a standard cytochrome
c oxidation assay: however since the affinity of nitrite for
reduced heme a3 is much lower than that for oxidized heme a3,
upon enzyme reduction dissociation of nitrite occurs yielding an
active enzyme. These new data led to the hypothesis that the
inhibitory effect of NO towards cytochrome-c-oxidase can be
explained by a combination of two different mechanisms
involving the reaction of NO with either heme a3
2+ or CuB
2+ (see
below). Additional experiments supporting the nitrite pathway
of inhibition were reported by Torres et al. [78] and Giuffrè et al.
[79]. These authors established that a fairly rapid reaction of NO
with cytochrome-c-oxidase occurs not only with O (the fully
oxidized enzyme devoid of chloride), but also with interme-
diates P and F (k ∼104 M−1 s−1 at 20 °C) (see at Fig. 4). As
originally proposed for the species O [76,77], also in the case of
intermediates P and F it was assumed that NO reacts at CuB
2+
[78,79]; it is however intriguing that a similar reaction of NO is
observed with the intermediate F of the CuB bacterial bd-type
terminal oxidase which lacks CuB (Borisov V. et al.,
unpublished data). As outlined above the rate constants for
the reaction of NO with O, P and F are much slower (>103-fold)
than that for the binding of NO to the reduced binuclear center;
nevertheless, as pointed out below, these intrinsic reactivities
should be confronted with the relative population of the
different O2 intermediates at the steady-state.
8. Two pathways for inhibition and the O2 competition
A scheme depicting the two pathways for the inhibition of
cytochrome-c-oxidase is shown in Fig. 6. On the left side the
reactions of NO with the three species carrying oxidized CuB
(O, P and F), with formation of the nitrite-oxidized heme a3
complex, are detailed; on the right, the reactions of NO withmediates having oxidized CuB (circled) react with NO yielding a transient nitrite-
ared) bind NO to give a ferrous nitrosyl derivative (bold). During turnover, the
ctron flux. Modified from Fig. 2 in [14] with permission.
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reduced (R) and possibly in the partially reduced state (E), are
shown. It is important to recall that the level of NO-inhibition of
cytochrome-c-oxidase activity depends on the [NO]/[O2] ratio
and, in this respect, binding to R is the only process which can
explain the observed competition between O2 and NO.
A point of interest is whether both pathways are necessary to
account for inhibition of respiration during turnover and, if this
was the case, under what conditions one or the other pathway
will prevail. A distinctive feature of the two pathways is that
while inhibition proceeding by reaction of NO with the reduced
heme a3 is photosensitive, the pathway leading to formation of
the nitrite-adduct of oxidized heme a3 is not. By studying the
effect of illumination on the rate of activity recovery from NO
inhibition, Sarti et al. [44] concluded that under conditions of
low electron flux (and high [O2]) the nitrite pathway prevails,
while as the electron flux is increased (and the O2 concentration
reduced), the competitive pathway with O2 tends to take over
(Fig. 6). In contrast, some groups have advocated that the
competitive inhibition with O2 (i.e., the pathway involving
reaction with R) is sufficient to account for the observations;
among others, Cadenas and co-workers published recently a
paper [80] with calculations indicating that the competitive
pathway is necessary and sufficient to explain inhibition.
However, there is experimental evidence supporting the
opposite viewpoint [71]. Since the pattern of competition with
O2 is obviously a major component in the discrimination
between the two pathways, extensive steady-state experiments
have been recently published by Mason et al. [71] to determine
inhibition parameters as a function of NO and O2 concentration,
as well as absolute turnover number of the enzyme. Mason et al.
[71] maintain that their data are incompatible with the
hypothesis that the competitive mechanism based on theFig. 7. Apparent IC50 for NO as a function of O2 at different turnover numbers
(TN). The saturation dependence, more evident at low TN (e− s−1 aa3
−1), is
inconsistent with a purely O2-competitive mechanism of inhibition by NO, and
rather demands the existence of the noncompetitive nitrite inhibition pathway.
Reproduced from [71] with permission.reaction of NO with R is sufficient to account for inhibition
(see Fig. 7); their results support the view that both inhibition
mechanisms are necessary. In addition, the steady-state data as a
function of absolute turnover number confirmed that the
pathway of inhibition depends on the reductive pressure, with
the noncompetitive pathway via formation of nitrite prevailing
at low electron flux [44].
If we accept that NO can inhibit cytochrome-c-oxidase via
multiple reactions occurring through two different pathways, an
additional consideration related to the absolute difference in
reactivity with NO as between the oxidized and reduced
enzyme, is in order. As outlined above, the very short half-life of
the O2 intermediates does not necessarily imply that their
population at steady-state is insignificant. This point is often
overlooked, since it is generally felt that the population of (say)
P and F should be minuscule given that their decay rates are so
fast. This is the case when and if the full complement of 4
electrons is already stored in the enzyme, as for the fully
reduced species; however, it is not applicable during turnover,
given that the rate of electron transfer from cytochrome c can
become rate limiting. Under these conditions, the overall
population of P, F and O can grow, as shown in the simulations
reported by Giuffrè et al. [79]. This consideration is particularly
important in assessing the likelihood of the reaction of NO with
the latter species during turnover.
In summary, the problem of inhibition of respiration by
NO may be summarized as follows. The O2-competitive
inhibition pathway that occurs through reaction of the fully
reduced binuclear center with NO will prevail under
conditions of high turnover, high reductive pressure and
low O2 concentrations; that is under condition in which the
relative population of R tends to increase (although generally
R is the least populated of the intermediates given its
reactivity towards O2). On the other hand, under conditions of
low turnover, low reductive pressure and high O2 concentra-
tions, the pathway proceeding via reaction of NO with the
oxidized-CuB containing intermediates and formation of the
nitrite-complex of oxidized heme a3 prevails. This seems
reasonable because in spite of their much lower rate of
reaction with NO, the species with oxidized CuB (O, P and F)
are overall more populated. Since their population probably
exceeds by orders of magnitude that of R and E, the non-
competitive pathway is possibly prevailing under physiolog-
ical conditions. Indeed experiments carried out with cells
seem to support this viewpoint [81]. A physiologically
relevant problem is the correlation between NO inhibition,
functionality of the respiratory chain and superoxide produc-
tion, at low O2 concentrations.
9. Biological role of NO control
An interesting issue is whether the NO control of
cytochrome-c-oxidase activity has an impact on cell physiol-
ogy. A number of hypotheses have been proposed, envisaging
different physiological and pathological implications of such a
control (see [34,82] for reviews). Firstly, we may consider
that depending on the fraction of cytochrome-c-oxidase
Fig. 8. Nitric oxide and mitochondrial oxygen reactive species. According to
[34], transient inhibition of cytochrome-c-oxidase by NO leads to enhanced
production of superoxide anion (O2
−), and thereby of H2O2 that acts as a
signaling molecule (a). When inhibition by NO is more persistent, the reaction
of NO with excess O2
− yields peroxynitrite (ONOO−) that causes irreversible
damages (b).
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NO flux), the O2 consumption and thereby ATP synthesis
may or may not decrease [83]. Under several conditions,
typically with mitochondria in state IV respiration, the overall
electron flux through the respiratory chain is, in fact,
controlled at the level of complex I rather than at
cytochrome-c-oxidase [84]: under these conditions, inhibition
of a fraction of cytochrome-c-oxidase will not result in a
decreased O2 consumption until the rate-control in the
respiratory chain shifts at the cytochrome-c-oxidase level, as
it occurs typically in state III respiring mitochondria [85].
When NO inhibition of cytochrome-c-oxidase has a net effect
on O2 consumption, an obvious consequence will be to
increase O2 availability. In this respect, an important role for
NO control of respiration has been envisaged in the
microcirculation system, and particularly for the cells located
at the boundary of capillaries: here the reduced O2
consumption induced by NO would indeed extend the zone
of tissue oxygenation away from blood vessels [26,86,87],
and this effect might synergize with the well documented
vasodilative properties of NO, leading to a more penetrating
oxygenation.
As pointed out by Moncada and Erusalimsky [34], when NO
inhibition of cytochrome-c-oxidase is such to reduce O2
consumption, a “metabolic hypoxia” is set whereby O2 cannot
be adequately used at the level of the mitochondrial respiratory
chain, and becomes available for other enzymatic functions over
and above respiration An interesting paradigm of such a NO-
dependent O2 diversion from the mitochondrion has been
reported in the control of firefly flashing [88]. In this insect, the
neurotransmitter octopamine has been proposed to activate
NOS; in a concerted manner, NO release and subsequent
inhibition of mitochondrial respiration makes O2 available for
the light-producing luciferin-luciferase reaction.
Another example of O2 diversion in response to NO
production has been documented in the case of the inactivation
of the hypoxia-inducible factor (HIF, [89]) pathway. HIF is a
heterodimeric transcriptional factor, composed of 1 subunit α
(HIF1α) and 1 subunit β (HIF1β), that upregulates gene
expression under hypoxic conditions. At higher O2 tensions, the
HIF pathway is inactivated by a family of O2-dependent prolyl
hydroxylases which target HIF1α for ubiquitination and
subsequent degradation. At lower O2 tension, NO can inactivate
HIF through the same mechanism, i.e., by rising the O2
concentration in the cell via inhibition of respiration.
Within the cell, mitochondria not only have a crucial role in
energy production, but also act as potential sources of signaling
molecules [34,90,91]. Among the mitochondrially-derived
signaling molecules, H2O2 is particularly important (Fig. 8). It
is worth recalling that cytochrome-c-oxidase inhibition induces
an accumulation of reducing equivalents upstream in the
respiratory chain, and leads to an enhanced production of
superoxide anion eventually converted to H2O2 by superoxide
dismutase. Thereby, the NO-dependent modulation of cyto-
chrome-c-oxidase activity might function to control mitochon-
drial H2O2 production, with effects on the downstream
signaling cascade [83,90].The situation is remarkably different when a more severe and
persistent cytochrome-c-oxidase inhibition by NO occurs.
Under these conditions the mitochondrion produces an excess
of O2
− that directly reacts with NO to yield peroxynitrite
(ONOO−, [92]), which in turn causes irreversible inhibition of
respiration (Fig. 8). These circumstances lead to a pathological
condition, termed “nitroxia” [82] in which the cell bioenergetics
is severely impaired (low ATP levels) by the extensive
nitrosative damages induced by ONOO− overproduction. The
persistence of this condition may eventually cause cell death
[34,93], unless compensatory defense mechanisms are trig-
gered. Such a compensation has been observed in astrocytes. In
these cells but not in neurons, NO inhibition of respiration
stimulates glycolytic ATP production, and cell protection from
death is ensured [94,95].
In conclusion, there are already clear indications that NO
inhibition of respiration, and particularly of cytochrome-c-
oxidase, has several physiological and pathological conse-
quences, but this field is moving fast and it is thus likely that
active ongoing research on these topics will shed light on further
biological effects, yet unknown.
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